There is a feeling of security in the size. Huge companies didn’t grow by accident. Instead, they are carefully built through superior management and foresight. Often these are more mature companies that also offer stability and predictability, usually at the expense of dynamic growth. These are yours Mega-cap stocks.
There is no one-size-fits-all definition of mega-cap stocks. Many define mega-cap as a company with a market capitalization of more than $ 100 billion. Needless to say, most of the mega-cap companies are headquartered in the US, Europe, and Japan. The commodities boom in 2000 caused many energy and raw materials companies to achieve mega-cap status, while the financial crisis resulted in some of the financial institutions losing mega-cap status.
Mega-caps are generally viewed as a stable safe haven for stock investors in times of uncertainty due to their size and industry dominance. The recent debt turmoil in Europe worries global left investors who are fleeing the euro into dollar-denominated assets such as government bonds and mega-cap stocks.
In a 2012 New York Time article, Wallace Weitz, president of the Weitz Fund said, “I’ve been doing this for over 40 years, but I still am surprised that people look away from good companies because they ‘don’t’ Done everything ‘for a long time. ”This is exactly where value investors should look for attractively valued stocks, he said.
This week I have mine Dividend growth stocks Database of stocks with a market capitalization of over $ 100 billion and a dividend yield of over 3.0%. The results are presented below:
Yield: 3.0% | Market Cap: $ 238.3 billion
Verizon Communications Inc. (VZ) is the largest US wireless operator, Verizon also offers fixed line and broadband services mainly in the northeastern United States. The company has paid a cash dividend to shareholders every year since 1984 and has increased its dividend payments for 13 consecutive years.
Yield: 4.4% | Market Cap: $ 233.4 billion
Abbvie Inc. (ABBV) is a global research-based pharmaceutical company that was formed as an independent entity after it spun off from Abbott Laboratories in early 2013. AbbVie’s main drug is Humira for rheumatoid arthritis. The company has paid a cash dividend to shareholders every year since 1926 and has increased its dividend payments for 49 consecutive years.
Yield: 5.2% | Market Cap: $ 198.2 billion
Yield: 5.2% | Market Cap: $ 205.6 billion
As with previous screens, the data presented above is in its raw form. Some of the companies would be disqualified for poor dividend fundamentals. However, some of the others may be worth additional due diligence.
My database, D4L-Data, is an Open Office table with more than 20 columns with information about the 150+ companies I track. The data is sortable and has built-in buttons and macros to make it easier to use. The list includes companies that have seen dividend growth in the past. The D4L data Spreadsheet is part of the D4L Premium Services and is updated every Saturday for subscribers.
Full disclosure: Lange KO, VZ, ABBV, CVX,
On the subject of matching items
Tags: KO, VZ, ABBV, CVX,